Control of lymphocyte homeostasis by iCD8a cells and osteopontin

iCD8a 细胞和骨桥蛋白对淋巴细胞稳态的控制

基本信息

项目摘要

SUMMARY In this application we propose to investigate the biological features of innate CD8α cells (or iCD8α cells), a novel lymphoid population present in the intestinal epithelium discovered by our group. A hallmark of this population is the expression of CD8αα, lack of T and B cell receptors, and the production of cytokines/chemokines that indicate an innate immune phenotype. iCD8α cells are a main source of osteoponin in the intestinal epithelium, a cytokine known for its role in tissue remodeling but also for its capacity to stimulate Th1 and Th17 immune responses. Interestingly, using a strain of mice lacking iCD8α cells (E8I mice; E8I is an essential enhancer for CD8αα expression in IEL) we found that the levels of -/- osteopontin in the intestinal epithelium are decreased in comparison to wild type mice, and that E8I-/- mice have a deficiency in NKp46+NK1.1+ IEL. These and other preliminary results have led to the hypothesis that iCD8α cells, through production of factors such as osteopontin, promote the survival and maintenance of IEL. In order to pursue this hypothesis, we propose the following complementary, yet independent aims: Aim1. To determine the contribution of iCD8α cells and osteopontin to IEL maintenance and survival. In this aim we will determine: a) the impact of iCD8α cells and osteopontin in the survival and proliferation of different IEL subsets; b) the impact of iCD8α cells and osteopontin in the immune environment of the intestines; and c) the role of osteopontin ligands in IEL homeostasis. Aim 2. To define the role of iCD8α cells and osteopontin during intestinal inflammation. In this section we will determine the role of iCD8α cells and osteopontin in three different disease models: a) intestinal inflammation by anti-CD40 antibody treatment, b) Citrobacter rodentium infection, and c) inflammation caused by adoptive transfer of effector T cells into immunodeficient mice. Aim 3. To determine the mechanisms controlling IEL homeostasis by iCD8α cells. Our previous publication indicates that IL-12 provides stimulus for activation of iCD8α cells. In this section we will determine a) the impact of IL-12 in activation of iCD8α cells, with implications on OPN secretion and IEL survival, and b) we will determine the gene expression signature of IEL responding to iCD8α cell/OPN stimulation.
总结

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Intestinal Intraepithelial Lymphocytes: Sentinels of the Mucosal Barrier.
  • DOI:
    10.1016/j.it.2017.11.003
  • 发表时间:
    2018-04
  • 期刊:
  • 影响因子:
    16.8
  • 作者:
    Olivares-Villagómez D;Van Kaer L
  • 通讯作者:
    Van Kaer L
Development, Homeostasis, and Functions of Intestinal Intraepithelial Lymphocytes.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Danyvid Olivares-Villagomez其他文献

Danyvid Olivares-Villagomez的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Danyvid Olivares-Villagomez', 18)}}的其他基金

Control of lymphocyte homeostasis by iCD8a cells and osteopontin
iCD8a 细胞和骨桥蛋白对淋巴细胞稳态的控制
  • 批准号:
    9381773
  • 财政年份:
    2017
  • 资助金额:
    $ 35.55万
  • 项目类别:
Characterization of CD8a cells as a novel immune population of the intestines
CD8a 细胞作为肠道新型免疫群体的表征
  • 批准号:
    9252837
  • 财政年份:
    2014
  • 资助金额:
    $ 35.55万
  • 项目类别:

相似海外基金

Effects of combining anti-CD40 and anti-CD11b mAb107 on survival of pig kidney xenografts in cynomolgus monkeys
抗CD40和抗CD11b mAb107联合使用对食蟹猴猪肾异种移植物存活的影响
  • 批准号:
    10425736
  • 财政年份:
    2022
  • 资助金额:
    $ 35.55万
  • 项目类别:
Effects of combining anti-CD40 and anti-CD11b mAb107 on survival of pig kidney xenografts in cynomolgus monkeys
抗CD40和抗CD11b mAb107联合使用对食蟹猴猪肾异种移植物存活的影响
  • 批准号:
    10618872
  • 财政年份:
    2022
  • 资助金额:
    $ 35.55万
  • 项目类别:
Control of Human NKT cell Responses by Immunoregulatory Liposomes and Anti- CD40 Antibody
通过免疫调节脂质体和抗 CD40 抗体控制人 NKT 细胞反应
  • 批准号:
    15K20115
  • 财政年份:
    2015
  • 资助金额:
    $ 35.55万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Creation of an Anti-CD40 Superagonistic Monoclonal Antibody
抗 CD40 超激动单克隆抗体的创建
  • 批准号:
    7672854
  • 财政年份:
    2009
  • 资助金额:
    $ 35.55万
  • 项目类别:
Preparation of activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody
使用青霉素灭活的化脓性链球菌 (OK432) 和抗 CD40 抗体制备能够在转移性癌症患者中启动肿瘤特异性细胞毒性 T 淋巴细胞的活化树突状细胞
  • 批准号:
    17591475
  • 财政年份:
    2005
  • 资助金额:
    $ 35.55万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ANTI-CD40 ANTIBODY IMMUNOTHERAPY IN SIV I INFECTION
SIV I 感染的抗 CD40 抗体免疫治疗
  • 批准号:
    6970822
  • 财政年份:
    2004
  • 资助金额:
    $ 35.55万
  • 项目类别:
Antitumor Mechanisms of anti-CD40/CpG-activated Macrophages
抗CD40/CpG激活巨噬细胞的抗肿瘤机制
  • 批准号:
    8306229
  • 财政年份:
    2002
  • 资助金额:
    $ 35.55万
  • 项目类别:
Antitumor Mechanisms of anti-CD40/CpG-activated Macrophages
抗CD40/CpG激活巨噬细胞的抗肿瘤机制
  • 批准号:
    7522880
  • 财政年份:
    2002
  • 资助金额:
    $ 35.55万
  • 项目类别:
Antitumor Mechanisms of anti-CD40/CpG-activated Macrophages
抗CD40/CpG激活巨噬细胞的抗肿瘤机制
  • 批准号:
    8117797
  • 财政年份:
    2002
  • 资助金额:
    $ 35.55万
  • 项目类别:
Antitumor Mechanisms of anti-CD40/CpG-activated Macrophages
抗CD40/CpG激活巨噬细胞的抗肿瘤机制
  • 批准号:
    7886648
  • 财政年份:
    2002
  • 资助金额:
    $ 35.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了